The Theranostic Value of STARD3 in Colorectal Cancer: The STAR Study: a Monocentric Observational Study
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
This study aims at verifying the overexpression of STARD3 in both early and advanced CRC patients derived tissues, to identify the pathways underpinning tumorigenesis and cancer progression in which STARD3 is involved. Moreover its role as a dynamic biomarker of treatment response and its part in treatment sensitivity will be explored.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:
• Histologically confirmed diagnosis of colorectal cancer, independently from diagnosis stage.
• Age ≥18 years.
• Signed informed consent form.
• Availability of tissue and blood samples stored at the Institutional Biobank for research purposes.
Locations
Other Locations
Italy
Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS
RECRUITING
Aviano
Contact Information
Primary
Vincenzo Canzonieri, MD, PhD
vcanzonieri@cro.it
0434 659 618
Time Frame
Start Date: 2023-05-22
Estimated Completion Date: 2032-12-31
Participants
Target number of participants: 150
Related Therapeutic Areas
Sponsors
Leads: Centro di Riferimento Oncologico - Aviano